Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2809 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 2.47 USD | -3.14% | -7.14% | -29.43% | -29.02% | 538.21 M USD | ||
| 2813 |  RGNX REGENXBIO Inc. - Common Stock | 8.09 USD | +6.45% | +6.73% | -6.26% | -39.76% | 534.05 M USD | ||
| 2818 |  NGNE Neurogene Inc. - Common Stock | 26.50 USD | +2.44% | -1.67% | -29.35% | -9.93% | 530.30 M USD | ||
| 2842 |  PBYI Puma Biotechnology Inc - Common Stock | 9.97 USD | +1.63% | +0.30% | +10.78% | +90.27% | 514.65 M USD | ||
| 2848 |  ALT Altimmune, Inc. - Common Stock | 2.60 USD | -2.26% | -7.14% | -21.69% | -35.48% | 505.75 M USD | ||
| 2852 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.66 USD | +5.73% | -3.49% | -8.79% | -20.19% | 501.86 M USD | ||
| 2865 |  VALN Valneva SE - American Depositary Shares | 5.69 USD | -3.07% | -1.39% | -14.31% | -47.12% | 493.72 M USD | ||
| 2867 |  ARVN Arvinas, Inc. - Common Stock | 7.51 USD | +0.81% | 0.00% | -13.38% | -19.25% | 491.05 M USD | ||
| 2883 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 1.40 USD | -2.10% | -10.83% | -19.08% | -2.78% | 483.69 M USD | ||
| 2894 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 1.77 USD | -2.21% | -4.32% | -11.50% | 0.00% | 471.11 M USD | ||
| 2903 |  CAPR Capricor Therapeutics, Inc. - Common Stock | 8.01 USD | -1.11% | -12.36% | -6.43% | +5.12% | 465.69 M USD | ||
| 2905 |  ASMB Assembly Biosciences, Inc. - Common Stock | 22.82 USD | -0.57% | -2.06% | -29.91% | -22.46% | 464.63 M USD | ||
| 2917 |  OVID Ovid Therapeutics Inc. - Common Stock | 2.34 USD | -0.85% | -5.26% | -12.69% | +29.28% | 457.00 M USD | ||
| 2921 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 4.56 USD | +4.59% | +9.62% | -12.31% | -50.49% | 453.48 M USD | ||
| 2931 |  SLN Silence Therapeutics Plc - American Depository Share | 9.52 USD | -3.05% | -11.61% | -28.85% | +76.30% | 449.79 M USD | ||
| 2933 |  RZLT Rezolute, Inc. - Common Stock | 4.64 USD | +5.94% | +12.35% | +15.14% | -47.33% | 448.79 M USD | ||
| 2938 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 22.75 USD | +0.18% | +0.09% | -24.32% | +32.65% | 444.75 M USD | ||
| 2944 |  PRTA Prothena Corporation plc - Ordinary Shares | 8.61 USD | +1.53% | -0.12% | -6.92% | -16.73% | 442.01 M USD | ||
| 2955 |  EDIT Editas Medicine, Inc. - Common Stock | 2.84 USD | +3.27% | +10.08% | +2.53% | -32.22% | 436.17 M USD | ||
| 2961 |  ENTX Entera Bio Ltd. - Ordinary Shares | 2.50 USD | -0.40% | -13.49% | -11.35% | 0.00% | 432.85 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |